Michael A. Kolodziej, MD: The American Society of Hematology [ASH] meeting every year often has a wide variety of presentations on malignant hematology. There’s all this information about sickle cell ...

New technologies can challenge how we see the world — opening doors to the study of previously impenetrable scientific problems and inspiring breakthroughs. At the same time, the latest ...

Thomas Hutson, DO, PharmD: This is a very exciting time for the management of kidney cancer. Over the past one to two decades based upon research that started in the 1990s, we have now a better ...

An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant. A stem cell transplant is one of the most efficient tools to ...

Concise review outlines key concepts behind using a patient’s own regenerative cells for point-of-care treatment of orthopedic indications and the advantages of this approach compared with other ...